
Enomark Pharma Private Limited
Pharmaceutical trading company based in Jodhpur, established in 2016.
Pharmaceutical trading company based in Jodhpur, established in 2016.
Enomark Pharma Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2016 (Eight years and 11 months 28 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Aerozest Life Science Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.50 Cr.
Shriram Patel, Umesh Patel, Laxmanram Patel, and One other member serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U51909MH2016PTC282093
282093
Private Limited Indian Non-Government Company
06 Jun 2016
30 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shriram Patel ![]() | Managing Director | 21-Jan-2022 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umesh Patel ![]() | Director | 21-Jan-2022 | Current |
Laxmanram Patel ![]() | Director | 30-Sep-2023 | Current |
Jetharam Patel ![]() | Director | 14-Jun-2024 | Current |
Enomark Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 1146.1% decrease in profit. The company's net worth Soared by an impressive increase of 1302.02%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
In 2023, Enomark Pharma had a promoter holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Shriram Patel and Laxmanram Patel are mutual person
Shriram Patel is a mutual person
Shriram Patel is a mutual person
Shriram Patel is a mutual person
Shriram Patel and Laxmanram Patel are mutual person
Shriram Patel and Laxmanram Patel are mutual person
₹7.50 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
06 Mar 2024 | Others | ₹7.50 Cr | Open |
Unlock and access historical data on people associated with Enomark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Enomark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enomark Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jetharam Patel was appointed as a Director was appointed as a Director on 14 Jun 2024 & has been associated with this company since 11 months 20 days .
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100907656 was registered on 06 Mar 2024.
Enomark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Laxmanram Ruparam Patel was appointed as a Director was appointed as a Director on 30 Sep 2023 & has been associated with this company since 1 year 8 months .
Enomark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Shriram Sawalram Patel was appointed as a Managing Director was appointed as a Managing Director on 21 Jan 2022 & has been associated with this company since 3 years 4 months .
Enomark Pharma Private Limited was incorporated on 06 Jun 2016.
The authorized share capital of Enomark Pharma Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.00 Cr.
Currently 4 directors are associated with Enomark Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Enomark Pharma Private Limited is 1/A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, India, Mumbai, Maharashtra, 400064.
The corporate identification number (CIN) of Enomark Pharma Private Limited is U51909MH2016PTC282093 and the company number is 282093 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Enomark Pharma Private Limited has fallen by -100.00%.
The financial reports for the fiscal year 2023 indicates that The net worth of Enomark Pharma Private Limited has experienced an upsurge of 1302.02%.
As per the financial statements for fiscal Year 2023, The total open charges for Enomark Pharma Private Limited amount to ₹ 7.50 Cr.
The most recent Balance Sheet for Enomark Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
HP
IP
MC
GR